High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
about
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisHigh-dose cyclophosphamide for severe aplastic anemia: long-term follow-upHigh-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trialThe reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesImmunotherapy for autoimmune and inflammatory renal diseases.Treatment of severe proliferative lupus nephritis: the current state.High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's diseaseManagement of refractory systemic rheumatic diseases.Autologous stem cell transplantation for systemic lupus erythematosus.Cyclophosphamide: new approaches for systemic lupus erythematosus.Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective.Lupus nephritis: a review of the current pharmacological treatments.Cyclophosphamide in lupus nephritis.Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.Blood stem cells as therapy for severe lupus.Emerging drug therapies for systemic lupus erythematosus.Systemic lupus erythematosus: current state of diagnosis and treatment.Systemic lupus erythematosus in children: current and emerging therapies.The use of stem cells for the treatment of autoimmune diseases.Stem cell transplantation for rheumatic autoimmune diseases.Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy.Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases.Update on emerging drug therapies for systemic lupus erythematosus.Novel approaches to therapy for systemic lupus erythematosus: update 2005.Management of systemic lupus erythematosus in Chinese patients.Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.Cyclophosphamide in dermatology.Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease.Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus.Multiple sclerosis and cancer: when two wrongs make a right?High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures.Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.Hematopoietic stem cell transplantation for systemic lupus erythematosus
P2860
Q24647406-F2C680BA-4691-49F0-887B-E0D593CF1BBCQ33747331-2E4821C9-C886-4D7A-AD34-A814572FA32FQ34027812-8BDB4ECF-3BF6-4FE7-B4FD-11C9B9862B86Q34514923-F4D51272-B6A8-465A-ACF1-1DDB27747D16Q34986999-868A649A-2DDB-4356-877B-0516888F2435Q35144046-9FF61559-221E-448B-9645-6899C0224111Q35201234-BE3A52DA-CC40-42F5-874B-A5F3A764A006Q35322297-11AC90C6-0C2B-44B7-B72F-2D2884DA7D8DQ35640956-B007B982-E7BB-441C-B8A5-228E48A46DA8Q35824509-8CA3E927-15C6-4B46-8FBD-35937FC2E7A8Q35824515-253279BD-B8E2-41B8-BD40-8AE825059700Q35870515-B92D7669-CB35-4E17-B6E9-F181A99BE52BQ35925513-8AE753DC-76BA-421D-B78A-B34C302BEBFBQ36054857-DE82BB0C-67AF-48DB-A9F4-967D83EC1CBDQ36164087-491986B2-3B9F-4248-8BF5-9B19C4DED1DAQ36239643-D4ABEF7B-2DF4-4A71-97C5-ECAFDE137493Q36634248-6A0EFAE2-2477-4448-A71B-1C15FEE82F6CQ36792304-D90C354C-FFB1-499A-8199-4BF11A318FBCQ36915688-E2903A9A-4AEA-4F5E-936B-76A6C3C39A65Q36916687-C856969A-42A6-470E-B43E-181045396CDEQ36993217-779B5036-D710-42F4-9F03-005AAD755093Q37038984-D6DCFE26-F79C-4008-A182-6D7962AD4465Q37311065-C90E0EE2-6382-4EBD-9CE0-7CDB82E59838Q37311073-A9395D3F-6D0F-40D0-BFAA-6BFDB1164570Q37690745-52918DEF-365C-450B-9BFC-5ADECA5A797CQ37754557-3F627976-43C6-40BD-8DA4-1F7503CCE371Q37754815-75BCF143-7D10-46D5-8652-1E8F4309EAA8Q38101015-15EB67B3-2E22-4349-B28A-678A8F568509Q38710150-F78A6E83-01E4-47D5-B926-530CC92DB61BQ43130006-B9089494-8013-4F3C-B7C0-5154F5696870Q43456564-C152F293-20F4-4980-A04E-97E5CAC20B6FQ44729424-9C2F1A7F-C29B-40C0-9B12-B4F86D0363C5Q46249526-3D90AADA-402E-4513-9BAE-949EDE261183Q50767841-9641A011-4EFE-46E8-9164-6E8A1581D7B6Q53871783-4CCFEAA6-FE4E-4978-95B2-D69E99BE8DD3Q58908910-CF69B3E5-E31B-4EAB-84FC-554068F233E4
P2860
High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@en
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@nl
type
label
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@en
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@nl
prefLabel
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@en
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@nl
P356
P1476
High-dose cyclophosphamide wit ...... systemic lupus erythematosus.
@en
P2093
Richard J Jones
Robert A Brodsky
P304
P356
10.1002/ART.10752
P577
2003-01-01T00:00:00Z